Peter Høngaard new Chairman of the Board in Scandion Oncology
Scandion Oncology A/S (“Scandion Oncology”) today announces that Peter Høngaard has accepted to take the role of Chairman of the Board as of October 1, 2019. With Peter Høngaard’s strong knowledge of developing life science businesses from research to commercialization Scandion Oncology is now taking full advantage of this added expertise in the Board. The current Chairman Jørgen Bardenfleth will now take the role of Vice-Chairman.“It is with my full support that we make this change of the Chairmanship of Scandion Oncology. Peter Høngaard brings a vast experience in building and running